![Biomedicines | Free Full-Text | The Percentage of Free PSA and Urinary Markers Distinguish Prostate Cancer from Benign Hyperplasia and Contribute to a More Accurate Indication for Prostate Biopsy Biomedicines | Free Full-Text | The Percentage of Free PSA and Urinary Markers Distinguish Prostate Cancer from Benign Hyperplasia and Contribute to a More Accurate Indication for Prostate Biopsy](https://www.mdpi.com/biomedicines/biomedicines-08-00173/article_deploy/html/images/biomedicines-08-00173-g001.png)
Biomedicines | Free Full-Text | The Percentage of Free PSA and Urinary Markers Distinguish Prostate Cancer from Benign Hyperplasia and Contribute to a More Accurate Indication for Prostate Biopsy
![PREDICTION OF POST-RADICAL PROSTATECTOMY PATHOLOGICAL OUTCOME FOR STAGE T1c PROSTATE CANCER WITH PERCENT FREE PROSTATE SPECIFIC ANTIGEN: A PROSPECTIVE MULTICENTER CLINICAL TRIAL | Journal of Urology PREDICTION OF POST-RADICAL PROSTATECTOMY PATHOLOGICAL OUTCOME FOR STAGE T1c PROSTATE CANCER WITH PERCENT FREE PROSTATE SPECIFIC ANTIGEN: A PROSPECTIVE MULTICENTER CLINICAL TRIAL | Journal of Urology](https://www.auajournals.org/cms/asset/9111e3f1-ba90-4265-9daa-0163bd194a10/si5.gif)
PREDICTION OF POST-RADICAL PROSTATECTOMY PATHOLOGICAL OUTCOME FOR STAGE T1c PROSTATE CANCER WITH PERCENT FREE PROSTATE SPECIFIC ANTIGEN: A PROSPECTIVE MULTICENTER CLINICAL TRIAL | Journal of Urology
![A predictive model for prostate cancer incorporating PSA molecular forms and age | Scientific Reports A predictive model for prostate cancer incorporating PSA molecular forms and age | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-58836-4/MediaObjects/41598_2020_58836_Fig1_HTML.png)
A predictive model for prostate cancer incorporating PSA molecular forms and age | Scientific Reports
![Improving the diagnosis of prostate cancer by telomerase-positive circulating tumor cells: A prospective pilot study - eClinicalMedicine Improving the diagnosis of prostate cancer by telomerase-positive circulating tumor cells: A prospective pilot study - eClinicalMedicine](https://www.thelancet.com/cms/asset/b0215ff1-1500-4862-940e-17c6d81d47b3/gr1.jpg)
Improving the diagnosis of prostate cancer by telomerase-positive circulating tumor cells: A prospective pilot study - eClinicalMedicine
![ROC curve of total PSA and percent free PSA (FT Ratio) in patients with... | Download Scientific Diagram ROC curve of total PSA and percent free PSA (FT Ratio) in patients with... | Download Scientific Diagram](https://www.researchgate.net/publication/13450180/figure/fig2/AS:669290739011591@1536582755278/ROC-curve-of-total-PSA-and-percent-free-PSA-FT-Ratio-in-patients-with-total.png)
ROC curve of total PSA and percent free PSA (FT Ratio) in patients with... | Download Scientific Diagram
![Age, total PSA, free PSA, and free/total PSA ratio in the two groups of... | Download Scientific Diagram Age, total PSA, free PSA, and free/total PSA ratio in the two groups of... | Download Scientific Diagram](https://www.researchgate.net/publication/342239723/figure/tbl2/AS:903395179249667@1592397603691/Age-total-PSA-free-PSA-and-free-total-PSA-ratio-in-the-two-groups-of-patients.png)
Age, total PSA, free PSA, and free/total PSA ratio in the two groups of... | Download Scientific Diagram
![Analytical performance of the VITROS® Immunodiagnostic Products total PSA II and free PSA assays - ScienceDirect Analytical performance of the VITROS® Immunodiagnostic Products total PSA II and free PSA assays - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0009912014003993-gr2.jpg)
Analytical performance of the VITROS® Immunodiagnostic Products total PSA II and free PSA assays - ScienceDirect
![Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging - ScienceDirect Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0090429500006373-gr1.gif)
Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging - ScienceDirect
![Predictive value of standard serum markers for bone metastases in prostate cancer | African Journal of Urology | Full Text Predictive value of standard serum markers for bone metastases in prostate cancer | African Journal of Urology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12301-021-00170-w/MediaObjects/12301_2021_170_Fig2_HTML.png)
Predictive value of standard serum markers for bone metastases in prostate cancer | African Journal of Urology | Full Text
![Prostate‐specific antigen: Current status - Brawer - 1999 - CA: A Cancer Journal for Clinicians - Wiley Online Library Prostate‐specific antigen: Current status - Brawer - 1999 - CA: A Cancer Journal for Clinicians - Wiley Online Library](https://acsjournals.onlinelibrary.wiley.com/cms/asset/b8312720-fdba-48c4-bc2d-231b95aa19ca/mtbl008.jpg)
Prostate‐specific antigen: Current status - Brawer - 1999 - CA: A Cancer Journal for Clinicians - Wiley Online Library
Age-Specific Cutoff Value for the Application of Percent Free Prostate-Specific Antigen (PSA) in Chinese Men with Serum PSA Levels of 4.0–10.0 ng/ml | PLOS ONE
![Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging - ScienceDirect Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0090429500006373-gr2.gif)